IPCA LABORATORIES LTD.
NSE : IPCALABBSE : 524494ISIN
CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse
: Ipca Laboratories
BSE2196.8561 (+2.86 % )
PREV CLOSE (Rs.) 2135.85
OPEN PRICE (Rs.) 2151.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 111547
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE2166.75 30.05 (+1.41 % )
PREV CLOSE(Rs.) 2136.70
OPEN PRICE (Rs.) 2139.80
BID PRICE (QTY) 2166.75 (67294 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8560495
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 27-Oct-2020 | 07-Nov-2020 | Interim Dividend & Quarterly Results |
| 26-Aug-2020 | 02-Sep-2020 | IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2020 ,inter alia, to consider and approve allotment of 5,00,000 equity shares of Rs. 2/- each fully paid-up of the Company to the members of the Promoters / Promoter Group upon conversion of warrants issued to them at the meeting of the Board of Directors of the Company held on 7th November, 2019 and pursuant to a resolution passed by the shareholders of the Company at the Extra Ordinary General Meeting held on 24th October, 2019. & Preferential Issue of shares |
| 29-Jul-2020 | 10-Aug-2020 | Quarterly Results |
| 05-Jun-2020 | 16-Jun-2020 | Audited Results |
| 20-Jan-2020 | 12-Feb-2020 | Quarterly Results |
| 24-Oct-2019 | 07-Nov-2019 | Quarterly Results |
| 20-Sep-2019 | 26-Sep-2019 | IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/09/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 26th September, 2019, inter-alia, to consider issuance of convertible warrants to promoters/ members of the promoter group of the Company on preferential basis, subject to the approval of the shareholders. |
| 22-Jul-2019 | 13-Aug-2019 | Quarterly Results |
| 08-May-2019 | 29-May-2019 | IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve 1. the Audited Financial Results for the 4th quarter and financial year ended 31st March, 2019; and 2. recommendation of dividend for the said financial year. |
| 21-Jan-2019 | 12-Feb-2019 | Quarterly Results |
